177 related articles for article (PubMed ID: 21703346)
1. Bioavailability and variability of biphasic insulin mixtures.
Søeborg T; Rasmussen CH; Mosekilde E; Colding-Jørgensen M
Eur J Pharm Sci; 2012 Jul; 46(4):198-208. PubMed ID: 21703346
[TBL] [Abstract][Full Text] [Related]
2. Absorption kinetics of insulin after subcutaneous administration.
Søeborg T; Rasmussen CH; Mosekilde E; Colding-Jørgensen M
Eur J Pharm Sci; 2009 Jan; 36(1):78-90. PubMed ID: 19028573
[TBL] [Abstract][Full Text] [Related]
3. Absorption kinetics of regular, isophane, and protamine zinc insulin in normal cats.
Wallace MS; Peterson ME; Nichols CE
Domest Anim Endocrinol; 1990 Oct; 7(4):509-15. PubMed ID: 2261761
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
Hildebrandt P
Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
[TBL] [Abstract][Full Text] [Related]
5. Absorption kinetics of regular and isophane (NPH) insulin in the normal dog.
Goeders LA; Esposito LA; Peterson ME
Domest Anim Endocrinol; 1987 Jan; 4(1):43-50. PubMed ID: 3333933
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue.
DeFelippis MR; Bakaysa DL; Bell MA; Heady MA; Li S; Pye S; Youngman KM; Radziuk J; Frank BH
J Pharm Sci; 1998 Feb; 87(2):170-6. PubMed ID: 9519149
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic model of human insulin following different routes of administration.
Potocka E; Baughman RA; Derendorf H
J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337
[TBL] [Abstract][Full Text] [Related]
8. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
9. Integrating advances in insulin into clinical practice: Overview of current insulin formulations.
Rhinehart AS
J Fam Pract; 2013 Sep; 62(9 Suppl Insulin):S4-8. PubMed ID: 24080572
[TBL] [Abstract][Full Text] [Related]
10. Insulin aspart pharmacokinetics: an assessment of its variability and underlying mechanisms.
Rasmussen CH; Røge RM; Ma Z; Thomsen M; Thorisdottir RL; Chen JW; Mosekilde E; Colding-Jørgensen M
Eur J Pharm Sci; 2014 Oct; 62():65-75. PubMed ID: 24878388
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins.
Hildebrandt P; Birch K; Sestoft L; Vølund A
Acta Med Scand; 1984; 215(1):69-73. PubMed ID: 6364700
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of protamine zinc recombinant human insulin in healthy dogs.
Clark M; Thomaseth K; Heit M; Hoenig M
J Vet Pharmacol Ther; 2012 Aug; 35(4):342-50. PubMed ID: 22758791
[TBL] [Abstract][Full Text] [Related]
13. [Insulin analogs].
Scaglione L; Cavallo-Perin P
Minerva Endocrinol; 1996 Mar; 21(1):27-36. PubMed ID: 8786740
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and miscibility of 4 highly purified porcine insulins: a study in vitro and in healthy volunteers.
Heine RJ; Van der Stap H; Salemink PJ; Kolkman-Roodbeen JC; Banken P; Gribnau TC; van der Veen EA
Diabetes Res; 1987 Jan; 4(1):45-50. PubMed ID: 3552367
[TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
Sintov AC; Levy HV; Botner S
J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
[TBL] [Abstract][Full Text] [Related]
16. Absorption kinetics of short- and intermediate-acting insulins after jet injection with Medi-Jector II.
Houtzagers CM; Berntzen PA; van der Stap H; Heine RJ; van der Veen EA
Diabetes Care; 1988 Oct; 11(9):739-42. PubMed ID: 3066607
[No Abstract] [Full Text] [Related]
17. Enhancement of oral bioavailability of insulin in humans.
Badwan A; Remawi M; Qinna N; Elsayed A; Arafat T; Melhim M; Hijleh OA; Idkaidek NM
Neuro Endocrinol Lett; 2009 Mar; 30(1):74-8. PubMed ID: 19300394
[TBL] [Abstract][Full Text] [Related]
18. Effect of insulin concentration on bioavailability during nasal spray administration.
Valensi P; Zirinis P; Nicolas P; Perret G; Sandre-Banon D; Attali JR
Pathol Biol (Paris); 1996 Apr; 44(4):235-40. PubMed ID: 8763584
[TBL] [Abstract][Full Text] [Related]
19. Absorption kinetics and action profiles of intermediate acting human insulins.
Bilo HJ; Heine RJ; Sikkenk AC; van der Meer J; van der Veen EA
Diabetes Res; 1987 Jan; 4(1):39-43. PubMed ID: 3552366
[TBL] [Abstract][Full Text] [Related]
20. Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins.
Heine RJ; Bilo HJ; Fonk T; van der Veen EA; van der Meer J
Diabetologia; 1984 Dec; 27(6):558-62. PubMed ID: 6397384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
